Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor

Prostate cancer is the most commonly diagnosed and second-most lethal cancer among men in the United States. The vast majority of prostate cancer deaths are due to castration-resistant prostate cancer (CRPC) – the lethal form of the disease that has progressed despite therapies that interfere with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Coleman, Daniel J., Van Hook, Kathryn, King, Carly J., Schwartzman, Jacob, Lisac, Robert, Urrutia, Joshua, Sehrawat, Archana, Woodward, Josha, Wang, Nicholas J., Gulati, Roman, Thomas, George V., Beer, Tomasz M., Gleave, Martin, Korkola, James E., Gao, Lina, Heiser, Laura M., Alumkal, Joshi J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130036/
https://www.ncbi.nlm.nih.gov/pubmed/27276681
http://dx.doi.org/10.18632/oncotarget.9816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130036/
https://www.ncbi.nlm.nih.gov/pubmed/27276681
http://dx.doi.org/10.18632/oncotarget.9816

Ejemplares similares